Journal of Genetic Medicine

Korean Society of Medical Genetics and Genomics (대한의학유전학회)
권호 표지
DOI QR코드

DOI QR Code

Analyzing clinical and genetic aspects of axonal Charcot-Marie-Tooth disease

  • Kwon, Hye Mi (Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Choi, Byung-Ok (Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2021.05.24
  • Accepted : 2021.09.03
  • Published : 2021.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Charcot-Marie-Tooth disease (CMT) is the most common hereditary motor and sensory peripheral neuropathy. CMT is usually classified into two categories based on pathology: demyelinating CMT type 1 (CMT1) and axonal CMT type 2 (CMT2) neuropathy. CMT1 can be distinguished by assessing the median motor nerve conduction velocity as greater than 38 m/s. The main clinical features of axonal CMT2 neuropathy are distal muscle weakness and loss of sensory and areflexia. In addition, they showed unusual clinical features, including delayed development, hearing loss, pyramidal signs, vocal cord paralysis, optic atrophy, and abnormal pupillary reactions. Recently, customized treatments for genetic diseases have been developed, and pregnancy diagnosis can enable the birth of a normal child when the causative gene mutation is found in CMT2. Therefore, accurate diagnosis based on genotype/phenotypic correlations is becoming more important. In this review, we describe the latest findings on the phenotypic characteristics of axonal CMT2 neuropathy. We hope that this review will be useful for clinicians in regard to the diagnosis and treatment of CMT.

Keywords

References

  1. Schroder JM. Neuropathology of Charcot-Marie-Tooth and related disorders. Neuromolecular Med 2006;8:23-42. https://doi.org/10.1385/NMM:8:1:23
  2. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980;103:259-80. https://doi.org/10.1093/brain/103.2.259
  3. Rudnik-Schoneborn S, Tolle D, Senderek J, Eggermann K, Elbracht M, Kornak U, et al. Diagnostic algorithms in Charcot-Marie-Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients. Clin Genet 2016;89:34-43. https://doi.org/10.1111/cge.12594
  4. Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011;69:22-33. https://doi.org/10.1002/ana.22166
  5. Rossor AM, Polke JM, Houlden H, Reilly MM. Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol 2013;9:562-71. https://doi.org/10.1038/nrneurol.2013.179
  6. Tooth HH. The peroneal type of progressive muscular atrophy [PhD dissertation]. London: H.K. Lewis; 1886.
  7. Charcot JM, Marie P. Sur une forme particuliere d'atrophie musculaire progressive souvent familiale debutant par les pieds et les jambes et atteignant plus tard les mains. Rev Med 1886;6:97-138.
  8. Pareyson D, Marchesi C. Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Lancet Neurol 2009;8:654-67. https://doi.org/10.1016/S1474-4422(09)70110-3
  9. Horacek O, Mazanec R, Morris CE, Kobesova A. Spinal deformities in hereditary motor and sensory neuropathy: a retrospective qualitative, quantitative, genotypical, and familial analysis of 175 patients. Spine (Phila Pa 1976) 2007;32:2502-8. https://doi.org/10.1097/BRS.0b013e3181573d4e
  10. Bamford NS, White KK, Robinett SA, Otto RK, Gospe SM Jr. Neuromuscular hip dysplasia in Charcot-Marie-Tooth disease type 1A. Dev Med Child Neurol 2009;51:408-11. https://doi.org/10.1111/j.1469-8749.2008.03234.x
  11. Werheid F, Azzedine H, Zwerenz E, Bozkurt A, Moeller MJ, Lin L, et al. Underestimated associated features in CMT neuropathies: clinical indicators for the causative gene? Brain Behav 2016;6:e00451.
  12. Saifee TA, Parees I, Kassavetis P, Kaski D, Bronstein AM, Rothwell JC, et al. Tremor in Charcot-Marie-Tooth disease: no evidence of cerebellar dysfunction. Clin Neurophysiol 2015;126:1817-24. https://doi.org/10.1016/j.clinph.2014.12.023
  13. Anzalone CL, Nuhanovic S, Olund AP, Carlson ML. Cochlear implantation in Charcot-Marie-Tooth disease: case report and review of the literature. Case Rep Med 2018;2018:1760978.
  14. Lerat J, Magdelaine C, Beauvais-Dzugan H, Espil C, Ghorab K, Latour P, et al. A novel pathogenic variant of NEFL responsible for deafness associated with peripheral neuropathy discovered through next-generation sequencing and review of the literature. J Peripher Nerv Syst 2019;24:139-44. https://doi.org/10.1111/jns.12310
  15. Sambuughin N, de Bantel A, McWilliams S, Sivakumar K. Deafness and CMT disease associated with a novel four amino acid deletion in the PMP22 gene. Neurology 2003;60:506-8. https://doi.org/10.1212/01.WNL.0000044048.27971.FC
  16. Nicholson G, Myers S. Intermediate forms of Charcot-Marie-Tooth neuropathy: a review. Neuromolecular Med 2006;8:123-30. https://doi.org/10.1385/NMM:8:1:123
  17. Papadakis CE, Hajiioannou JK, Kyrmizakis DE, Bizakis JG. Bilateral sudden sensorineural hearing loss caused by Charcot-Marie-Tooth disease. J Laryngol Otol 2003;117:399-401. https://doi.org/10.1258/002221503321626465
  18. Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 2001;105:587-97. https://doi.org/10.1016/S0092-8674(01)00363-4
  19. Reilly MM. Axonal Charcot-Marie-Tooth disease: the fog is slowly lifting! Neurology 2005;65:186-7. https://doi.org/10.1212/01.wnl.0000173904.97549.94
  20. Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004;36:449-51. https://doi.org/10.1038/ng1341
  21. Honda S, Aihara T, Hontani M, Okubo K, Hirose S. Mutational analysis of action of mitochondrial fusion factor mitofusin-2. J Cell Sci 2005;118(Pt 14):3153-61. https://doi.org/10.1242/jcs.02449
  22. Nicholson GA, Magdelaine C, Zhu D, Grew S, Ryan MM, Sturtz F, et al. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations. Neurology 2008;70:1678-81. https://doi.org/10.1212/01.wnl.0000311275.89032.22
  23. Verhoeven K, De Jonghe P, Coen K, Verpoorten N, Auer-Grumbach M, Kwon JM, et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 2003;72:722-7. https://doi.org/10.1086/367847
  24. De Sandre-Giovannoli A, Chaouch M, Kozlov S, Vallat JM, Tazir M, Kassouri N, et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 2002;70:726-36. https://doi.org/10.1086/339274
  25. Leal A, Huehne K, Bauer F, Sticht H, Berger P, Suter U, et al. Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models. Neurogenetics 2009;10:275-87. https://doi.org/10.1007/s10048-009-0183-3
  26. Klein CJ, Shi Y, Fecto F, Donaghy M, Nicholson G, McEntagart ME, et al. TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot-Marie-Tooth neuropathies. Neurology 2011;76:887-94. https://doi.org/10.1212/WNL.0b013e31820f2de3
  27. Klein CJ, Cunningham JM, Atkinson EJ, Schaid DJ, Hebbring SJ, Anderson SA, et al. The gene for HMSN2C maps to 12q23-24: a region of neuromuscular disorders. Neurology 2003;60:1151-6. https://doi.org/10.1212/01.WNL.0000055900.30217.EA
  28. Rebelo AP, Abrams AJ, Cottenie E, Horga A, Gonzalez M, Bis DM, et al. Cryptic amyloidogenic elements in the 3' UTRs of neurofilament genes trigger axonal neuropathy. Am J Hum Genet 2016;98:597-614. https://doi.org/10.1016/j.ajhg.2016.02.022
  29. Brownlees J, Ackerley S, Grierson AJ, Jacobsen NJ, Shea K, Anderton BH, et al. Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum Mol Genet 2002;11:2837-44. https://doi.org/10.1093/hmg/11.23.2837
  30. Antonellis A, Ellsworth RE, Sambuughin N, Puls I, Abel A, Lee-Lin SQ, et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 2003;72:1293-9. https://doi.org/10.1086/375039
  31. Lassuthova P, Rebelo AP, Ravenscroft G, Lamont PJ, Davis MR, Manganelli F, et al. Mutations in ATP1A1 cause dominant Charcot-MarieTooth type 2. Am J Hum Genet 2018;102:505-14. https://doi.org/10.1016/j.ajhg.2018.01.023
  32. Carter J, Gragerov A, Konvicka K, Elder G, Weinstein H, Lazzarini RA. Neurofilament (NF) assembly; divergent characteristics of human and rodent NF-L subunits. J Biol Chem 1998;273:5101-8. https://doi.org/10.1074/jbc.273.9.5101
  33. Irobi J, Van Impe K, Seeman P, Jordanova A, Dierick I, Verpoorten N, et al. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet 2004;36:597-601. https://doi.org/10.1038/ng1328
  34. Barhoumi C, Amouri R, Ben Hamida C, Ben Hamida M, Machghoul S, Gueddiche M, et al. Linkage of a new locus for autosomal recessive axonal form of Charcot-Marie-Tooth disease to chromosome 8q21.3. Neuromuscul Disord 2001;11:27-34. https://doi.org/10.1016/S0960-8966(00)00162-0
  35. De Jonghe P, Timmerman V, Ceuterick C, Nelis E, De Vriendt E, Lofgren A, et al. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 1999;122(Pt 2):281-90. https://doi.org/10.1093/brain/122.2.281
  36. Birouk N, Azzedine H, Dubourg O, Muriel MP, Benomar A, Hamadouche T, et al. Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene. Arch Neurol 2003;60:598-604. https://doi.org/10.1001/archneur.60.4.598
  37. Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 1998;50:1397-401. https://doi.org/10.1212/WNL.50.5.1397
  38. Senderek J, Hermanns B, Lehmann U, Bergmann C, Marx G, Kabus C, et al. Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: two novel amino acid substitutions (Asp61Gly; Tyr119Cys) and a possible "hotspot" on Thr124Met. Brain Pathol 2000;10:235-48. https://doi.org/10.1111/j.1750-3639.2000.tb00257.x
  39. Claramunt R, Pedrola L, Sevilla T, Lopez de Munain A, Berciano J, Cuesta A, et al. Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect. J Med Genet 2005;42:358-65. https://doi.org/10.1136/jmg.2004.022178
  40. Chung KW, Kim SM, Sunwoo IN, Cho SY, Hwang SJ, Kim J, et al. A novel GDAP1 Q218E mutation in autosomal dominant Charcot-Marie-Tooth disease. J Hum Genet 2008;53:360-4. https://doi.org/10.1007/s10038-008-0249-3
  41. Tang BS, Zhao GH, Luo W, Xia K, Cai F, Pan Q, et al. Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum Genet 2005;116:222-4. https://doi.org/10.1007/s00439-004-1218-3
  42. Fabrizi GM, Ferrarini M, Cavallaro T, Cabrini I, Cerini R, Bertolasi L, et al. Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease. Neurology 2007;69:291-5. https://doi.org/10.1212/01.wnl.0000265820.51075.61
  43. Latour P, Thauvin-Robinet C, Baudelet-Mery C, Soichot P, Cusin V, Faivre L, et al. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet 2010;86:77-82. https://doi.org/10.1016/j.ajhg.2009.12.005
  44. Weedon MN, Hastings R, Caswell R, Xie W, Paszkiewicz K, Antoniadi T, et al. Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet 2011;89:308-12. https://doi.org/10.1016/j.ajhg.2011.07.002
  45. Weterman MA, Sorrentino V, Kasher PR, Jakobs ME, van Engelen BG, Fluiter K, et al. A frameshift mutation in LRSAM1 is responsible for a dominant hereditary polyneuropathy. Hum Mol Genet 2012;21:358-70. https://doi.org/10.1093/hmg/ddr471
  46. Xu WY, Gu MM, Sun LH, Guo WT, Zhu HB, Ma JF, et al. A nonsense mutation in DHTKD1 causes Charcot-Marie-Tooth disease type 2 in a large Chinese pedigree. Am J Hum Genet 2012;91:1088-94. https://doi.org/10.1016/j.ajhg.2012.09.018
  47. Ylikallio E, Poyhonen R, Zimon M, De Vriendt E, Hilander T, Paetau A, et al. Deficiency of the E3 ubiquitin ligase TRIM2 in early-onset axonal neuropathy. Hum Mol Genet 2013;22:2975-83. https://doi.org/10.1093/hmg/ddt149
  48. Cottenie E, Kochanski A, Jordanova A, Bansagi B, Zimon M, Horga A, et al. Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2. Am J Hum Genet 2014;95:590-601. https://doi.org/10.1016/j.ajhg.2014.10.002
  49. Higuchi Y, Hashiguchi A, Yuan J, Yoshimura A, Mitsui J, Ishiura H, et al. Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2. Ann Neurol 2016;79:659-72. https://doi.org/10.1002/ana.24612
  50. Gonzalez M, McLaughlin H, Houlden H, Guo M, Yo-Tsen L, Hadjivassilious M, et al.; Inherited Neuropathy Consortium. Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2. J Neurol Neurosurg Psychiatry 2013;84:1247-9. https://doi.org/10.1136/jnnp-2013-305049
  51. Tetreault M, Gonzalez M, Dicaire MJ, Allard P, Gehring K, Leblanc D, et al. Adult-onset painful axonal polyneuropathy caused by a dominant NAGLU mutation. Brain 2015;138(Pt 6):1477-83. https://doi.org/10.1093/brain/awv074
  52. Vester A, Velez-Ruiz G, McLaughlin HM; NISC Comparative Sequencing Program; Lupski JR, Talbot K, et al. A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo. Hum Mutat 2013;34:191-9. https://doi.org/10.1002/humu.22210
  53. Montecchiani C, Pedace L, Lo Giudice T, Casella A, Mearini M, Gaudiello F, et al. ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease. Brain 2016;139(Pt 1):73-85. https://doi.org/10.1093/brain/awv320
  54. Gonzalez MA, Feely SM, Speziani F, Strickland AV, Danzi M, Bacon C, et al. A novel mutation in VCP causes Charcot-Marie-Tooth type 2 disease. Brain 2014;137(Pt 11):2897-902. https://doi.org/10.1093/brain/awu224
  55. Albulym OM, Kennerson ML, Harms MB, Drew AP, Siddell AH, Auer-Grumbach M, et al. MORC2 mutations cause axonal Charcot-Marie-Tooth disease with pyramidal signs. Ann Neurol 2016;79:419-27. https://doi.org/10.1002/ana.24575
  56. Takashima H, Nakagawa M, Nakahara K, Suehara M, Matsuzaki T, Higuchi I, et al. A new type of hereditary motor and sensory neuropathy linked to chromosome 3. Ann Neurol 1997;41:771-80. https://doi.org/10.1002/ana.410410613
  57. Ishiura H, Sako W, Yoshida M, Kawarai T, Tanabe O, Goto J, et al. The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement. Am J Hum Genet 2012;91:320-9. https://doi.org/10.1016/j.ajhg.2012.07.014
  58. Lee SS, Lee HJ, Park JM, Hong YB, Park KD, Yoo JH, et al. Proximal dominant hereditary motor and sensory neuropathy with proximal dominance association with mutation in the TRK-fused gene. JAMA Neurol 2013;70:607-15. https://doi.org/10.1001/jamaneurol.2013.1250
  59. Choi BO, Kang SH, Hyun YS, Kanwal S, Park SW, Koo H, et al. A complex phenotype of peripheral neuropathy, myopathy, hoarseness, and hearing loss is linked to an autosomal dominant mutation in MYH14. Hum Mutat 2011;32:669-77. https://doi.org/10.1002/humu.21488
  60. Iyadurai S, Arnold WD, Kissel JT, Ruhno C, Mcgovern VL, Snyder PJ, et al. Variable phenotypic expression and onset in MYH14 distal hereditary motor neuropathy phenotype in a large, multigenerational North American family. Muscle Nerve 2017;56:341-5. https://doi.org/10.1002/mus.25491
  61. Almutawa W, Smith C, Sabouny R, Smit RB, Zhao T, Wong R, et al. The R941L mutation in MYH14 disrupts mitochondrial fission and associates with peripheral neuropathy. EBioMedicine 2019;45:379-92. https://doi.org/10.1016/j.ebiom.2019.06.018
  62. Zimon M, Baets J, Almeida-Souza L, De Vriendt E, Nikodinovic J, Parman Y, et al. Loss-of-function mutations in HINT1 cause axonal neuropathy with neuromyotonia. Nat Genet 2012;44:1080-3. https://doi.org/10.1038/ng.2406
  63. Hong YB, Kang J, Kim JH, Lee J, Kwak G, Hyun YS, et al. DGAT2 mutation in a family with autosomal-dominant early-onset axonal Charcot-Marie-Tooth disease. Hum Mutat 2016;37:473-80. https://doi.org/10.1002/humu.22959